Molecular Diagnostics

Transforming testing & treatment together

As pioneers of polymerase chain reaction (PCR) technology, we continue to demonstrate our commitment to scientific and clinical excellence. Roche systems and assays are the trusted choice in clinical trials across the industry —from plasma and blood screening and viral load testing to more recent leadership with HPV Primary Screening and advances in oncology testing with the cobas^® EGFR Mutation Test v2. We hold our products to the highest performance standards to give you confidence in every result.

Assay Offerings

Proven Performance

Roche is committed to continued scientific and clinical excellence using Nobel-prize-winning PCR technology.

Trusted results and simplified workflows across a full range of throughputs

cobas® 4800 System

Highly efficient, flexible workflows and a consolidated assay menu deliver confidence with every result. Automated PCR setup and analysis help make the most of your resources and reduce error.

cobas® 6800 System

Unparalleled performance, absolute automation, and unmatched flexibility. Meet the needs of molecular testing today and experience the freedom to explore the possibilities for tomorrow.

cobas® 8800 System

Unparalleled performance with minimal operator interaction revolutionizes the future of highthroughput applications.

MagNA Pure 24 System

Flexible runs start here. Scalable extraction of 1-24 samples, plus a fast protocol option, make this the ideal solution for the real needs of modern labs.

MagNA Pure 96 System

Automatically isolate nucleic acids from a wide range of sample types while optimizing laboratory productivity and scalability.

cobas® Liat® System

Expertly designed to combine a small footprint with rapid turnaround time and ease of use. Bringing premium PCR performance to point-of-care locations; and the flexibility to laboratories.

^References

^{1. Performance evaluation of the new real-time PCR-based cobas® HCV assay for use on the cobas® 6800/8800 systems for the detection and quantification of HCV RNA - RING Study. Poster presented at AASLD, Nov 11-14, 2016, Boston, MA, USA.}